inflammation mediators

Immune profiling of COVID-19: preliminary findings and implications for the pandemic
Holden T Maecker

Journal for ImmunoTherapy of Cancer May 2021, 9 (5) e002550; DOI: 10.1136/jitc-2021-002550
Shared inflammatory pathways and therapeutic strategies in COVID-19 and cancer immunotherapy
Lorenzo Iovino, Laurel A Thur, Sacha Gnjatic, Aude Chapuis, Filippo Milano, Joshua A Hill

Journal for ImmunoTherapy of Cancer May 2021, 9 (5) e002392; DOI: 10.1136/jitc-2021-002392
The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response
Fernanda I Arnaldez, Steven J O'Day, Charles G Drake, Bernard A Fox, Bingqing Fu, Walter J Urba, Vincenzo Montesarchio, Jeffrey S Weber, Haiming Wei, Jon M Wigginton, Paolo Antonio Ascierto

Journal for ImmunoTherapy of Cancer May 2020, 8 (1) e000930; DOI: 10.1136/jitc-2020-000930
Heat shock and HSP70 regulate 5-FU-mediated caspase-1 activation in myeloid-derived suppressor cells and tumor growth in mice
Thomas Pilot, Aurélie Fratti, Chloé Thinselin, Anaïs Perrichet, Lucie Demontoux, Emeric Limagne, Valentin Derangère, Alis Ilie, Mané Ndiaye, Elise Jacquin, Carmen Garrido, François Ghiringhelli, Fanny Chalmin, Cédric Rébé

Journal for ImmunoTherapy of Cancer May 2020, 8 (1) e000478; DOI: 10.1136/jitc-2019-000478
Early changes in immune cell subsets with corticosteroids in patients with solid tumors: implications for COVID-19 management
Jennifer L Marté, Nicole J Toney, Lisa Cordes, Jeffrey Schlom, Renee N Donahue, James L Gulley

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (2) e001019; DOI: 10.1136/jitc-2020-001019
2,5-dimethylcelecoxib improves immune microenvironment of hepatocellular carcinoma by promoting ubiquitination of HBx-induced PD-L1
Zhanfei Chen, Yiyin Chen, Lirong Peng, Xiaoqian Wang, Nanhong Tang

Journal for ImmunoTherapy of Cancer Oct 2020, 8 (2) e001377; DOI: 10.1136/jitc-2020-001377
Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy
Vincenzo Montesarchio, Roberto Parrella, Chiara Iommelli, Antonella Bianco, Elio Manzillo, Fiorentino Fraganza, Cristiana Palumbo, Gaetano Rea, Patrizia Murino, Rosanna De Rosa, Luigi Atripaldi, Maurizio D’Abbraccio, Marcello Curvietto, Domenico Mallardo, Egidio Celentano, Antonio Maria Grimaldi, Marco Palla, Claudia Trojaniello, Maria Grazia Vitale, Samuel Lewis Million-Weaver, Paolo Antonio Ascierto

Journal for ImmunoTherapy of Cancer Aug 2020, 8 (2) e001089; DOI: 10.1136/jitc-2020-001089

Main menu

inflammation mediators

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

inflammation mediators

Pages